The mosquito midgut plays a central role in the sporogonic development of malaria parasites. We have found that polyclonal sera, produced against mosquito midguts, blocked the passage of Plasmodium falciparum ookinetes across the midgut, leading to a significant reduction of infections in mosquitoes. Anti-midgut mAbs were produced that display broad-spectrum activity, blocking parasite development of both P. falciparum and Plasmodium vivax parasites in five different species of mosquitoes. In addition to their parasite transmission-blocking activity, these mAbs also reduced mosquito survivorship and fecundity. These results reveal that mosquito midgut-based antibodies have the potential to reduce malaria transmission in a synergistic manner by lowering both vector competence, through transmission-blocking effects on parasite development, and vector abundance, by decreasing mosquito survivorship and egg laying capacity. Because the intervention can block transmission of different malaria parasite species in various species of mosquitoes, vaccines against such midgut receptors may block malaria transmission worldwide.O f the several hundred species of Anopheles mosquitoes worldwide, only about 20 are major vectors of human malaria. Several components contribute to this fact, including the propensity of a given species to feed on humans, the average longevity of a mosquito species, and the innate ability of a species to permit development of the parasite (i.e., vector competence). Different intervention strategies attempt to reduce malaria transmission by reducing these various components. Reducing vector competence is the primary objective behind two rapidly evolving areas of research in malaria and other vector-borne diseases, namely the replacement of natural vector populations with populations genetically engineered for refractoriness and transmission-blocking immunity (TBI).Transmission-blocking vaccines in malaria are envisioned to inhibit the developmental stages of the malaria parasites in the mosquito midgut. The first 48 h after ingestion of an infective blood meal is the most critical time period for malaria parasite development within the mosquito. It is during this time that the parasite fertilization takes place and the resulting zygotes transform into motile ookinetes. Ookinetes traverse the midgut and lodge between the basal lamina and midgut epithelia, where they encyst and develop into sporozoite-producing oocysts.Several studies with rodent and human malaria parasites have revealed that the ookinete-to-oocyst transition is the most vulnerable link in sporogonic development of malaria parasites (1-3). Thus, the developing parasite stages in the mosquito midgut provide an ideal target for transmission-blocking vaccines. Efforts in transmission-blocking vaccines in malaria have focused primarily on the use of specific parasite antigens as targets of immune intervention in the mosquito midgut. Antibodies against parasite antigens block fertilization and͞or prevent the movement of ookinetes across the...